Skip to Content

OPKO Health Inc OPK

Morningstar Rating
$1.38 +0.01 (0.37%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

OPK is trading at a 647% premium.
Price
$1.36
Fair Value
$6.48
Uncertainty
Very High
1-Star Price
$6.89
5-Star Price
$6.88
Economic Moat
Jbtx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if OPK is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.37
Day Range
$1.351.40
52-Week Range
$0.852.22
Bid/Ask
$1.37 / $1.38
Market Cap
$958.36 Mil
Volume/Avg
611,915 / 3.5 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.27
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Value
Total Number of Employees
3,930

Comparables

Valuation

Metric
OPK
09960
4595
Price/Earnings (Normalized)
43.175.69
Price/Book Value
0.760.442.09
Price/Sales
1.271.292.82
Price/Cash Flow
87.3512.02
Price/Earnings
OPK
09960
4595

Financial Strength

Metric
OPK
09960
4595
Quick Ratio
0.953.556.00
Current Ratio
1.913.647.19
Interest Coverage
−13.28−3.92
Quick Ratio
OPK
09960
4595

Profitability

Metric
OPK
09960
4595
Return on Assets (Normalized)
−10.82%0.98%31.82%
Return on Equity (Normalized)
−15.64%1.29%38.52%
Return on Invested Capital (Normalized)
−12.10%−0.85%38.27%
Return on Assets
OPK
09960
4595
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
PhpqrfsgxJjl$207.2 Bil
Danaher Corp
DHR
MssqmkmzmKlfpk$182.4 Bil
IDEXX Laboratories Inc
IDXX
FgywgmbdHntqh$40.3 Bil
IQVIA Holdings Inc
IQV
TsdrhhtzMhpjnm$40.0 Bil
Agilent Technologies Inc
A
GljrpryfDvgb$38.2 Bil
Mettler-Toledo International Inc
MTD
VvsswjcfnyMhdlqn$29.0 Bil
Icon PLC
ICLR
JcrccxqclXvqbfs$27.7 Bil
Illumina Inc
ILMN
ChkdtzczBbycsr$18.8 Bil
Waters Corp
WAT
CddgxnrkMvz$17.9 Bil
Labcorp Holdings Inc
LH
JxksdsqnjCqlngd$17.4 Bil

Sponsor Center